Indorama Ventures Limited reported Q2 FY24 revenue of $4 billion, up 5 per cent QoQ and flat YoY.
Sales volume grew 3 per cent QoQ and 1 per cent YoY.
Adjusted EBITDA was $370 million, up 1 per cent QoQ but down 11 per cent YoY.
Key segments, including combined PET and specialty chemicals, faced mixed results, with notable growth in PET HVA.
Sales volume grew 3 per cent QoQ and 1 per cent YoY.
Adjusted EBITDA was $370 million, up 1 per cent QoQ but down 11 per cent YoY.
Key segments, including combined PET and specialty chemicals, faced mixed results, with notable growth in PET HVA.
